Aptose Enters into $15.5 Million Common Shares Purchase Agreement with Aspire Capital Fund, LLC Oct 30, 2017 8:00am EDT
Aptose Biosicences and CrystalGenomics Announce Issuance of U.S. Patent for CG’806 Sep 12, 2017 8:00am EDT
Aptose Biosciences to Present at the 19th Annual Rodman & Renshaw Global Investment Conference Sep 05, 2017 8:30am EDT
Aptose Biosciences to Present at Canaccord Genuity 37th Annual Growth Conference Aug 03, 2017 8:30am EDT
Aptose To Release Second Quarter Ended June 30, 2017 Financial Results and Hold Conference Call on August 8, 2017 Aug 01, 2017 8:30am EDT
Preclinical Data on Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented at AACR Hematologic Malignancies Meeting May 08, 2017 8:00am EDT
